EXHIBIT 107
Calculation of Filing Fee Tables
Form F-1
(Form Type)
Medicus Pharma Ltd.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule or Instruction | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |
Newly Registered Securities | ||||||||
Fees to Be Paid | Equity | Units, each consisting of one Common Share, no par value, and one Warrant (1),(2) | 457(o) | $15,000,000 (3) | $147.60 per $1,000,000 | $2,214 | ||
Equity | Common shares, no par value per share, included as part of the Units(1),(2) | 457(g) | - | - | (4) | |||
Equity | Warrants included as part of the Units(1),(2) | 457(g) | - | - | (4) | |||
Fees Previously Paid | - | - | - | - | - | - | - | - |
Total Offering Amounts | $15,000,000 | $2,214 | ||||||
Total Fees Previously Paid | N/A | |||||||
Total Fee Offsets | $0 | |||||||
Net Fee Due | $2,214 |
(1) Pursuant to Rule 416(a) under the Securities Act, the Registrant is also registering an indeterminate number of additional securities that shall be issuable pursuant to Rule 416 to prevent dilution resulting from share splits, share dividends or similar transactions.
(2) Includes the aggregate offering price of additional securities that the underwriters have a 45-day option to purchase to cover over-allotments, if any.
(3) Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933.
(4) In accordance with Rule 457(g) under the Securities Act, because the Registrant's common shares underlying the warrants are registered hereby, no separate registration fee is required with respect to the warrants registered hereby.